Eikon Therapeutics is a new biopharmaceutical company employing the revolutionary technology of single molecule imaging at the interface of chemistry, engineering and biology to discover novel treatments for life-threatening diseases. Eikon’s live cell imaging drug discovery platform is built on groundbreaking innovations from its founders who pioneered the field of in vivo single-molecule microscopy (Nobel Prize, 2014).